Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta(2)-Adrenergic receptor polymorphisms and asthma.

L Joos1, P D Paré, A J Sandford

  • 1University of British Columbia Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, British Columbia, Canada.

Current Opinion in Pulmonary Medicine
|February 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial respiration modulates Hsf1 activation and the heat shock response.

bioRxiv : the preprint server for biology·2026
Same author

Implications of Codon Usage, tRNA Gene Redundancy and tRNA Gene Clustering in Experimental Models of Mistranslation.

Journal of molecular biology·2025
Same author

Soil under stress: The importance of soil life and how it is influenced by (micro)plastic pollution.

Computational and structural biotechnology journal·2022
Same author

Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib.

Clinical and experimental dermatology·2021
Same author

Hedgehog signaling in the airway epithelium of patients with chronic obstructive pulmonary disease.

Scientific reports·2019
Same author

Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.

Genetics and molecular research : GMR·2016
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Genetic variations in the beta(2)-adrenergic receptor gene are linked to asthma. Research is exploring how these gene changes affect asthma and response to bronchodilator medications.

Area of Science:

  • Pharmacogenetics
  • Respiratory Medicine
  • Molecular Biology

Background:

  • A long-standing hypothesis links abnormalities in the beta(2)-adrenergic receptor to asthma pathogenesis.
  • The discovery of functionally relevant polymorphisms in the beta(2)-adrenergic receptor gene has spurred significant research.

Purpose of the Study:

  • To summarize recent advancements in the study of beta(2)-adrenergic receptor gene polymorphisms and their association with asthma.
  • To review the impact of these polymorphisms on asthma phenotypes and bronchodilator responsiveness.

Main Methods:

  • Review of existing literature on beta(2)-adrenergic receptor gene polymorphisms.
  • Analysis of studies investigating the relationship between these polymorphisms and asthma.
  • Examination of data on bronchodilator response in relation to genetic variations.

Related Experiment Videos

Main Results:

  • Evidence suggests a connection between specific beta(2)-adrenergic receptor gene polymorphisms and asthma susceptibility.
  • Polymorphisms influence the effectiveness of bronchodilator treatments in asthma patients.
  • Variations in the receptor gene are associated with different asthma-related phenotypes.

Conclusions:

  • The beta(2)-adrenergic receptor gene is a significant factor in asthma development and treatment response.
  • Further research into these genetic variations can personalize asthma management strategies.
  • Understanding the pharmacogenetics of the beta(2)-adrenergic receptor is crucial for advancing asthma care.